Therma Bright: Over-the-Counter Medical Devices for Dermatological Needs

Therma Bright is a progressive medical technology company. They're focusing on providing consumers and healthcare professionals with high quality medi …

Therma Bright medical device pain relief

Over-the-counter medical devices

Therma Bright is a progressive medical technology company. They're focusing on providing consumers and healthcare professionals with high quality medical devices that meet their medical and health care needs.

"People want to deal with their health issues at home. We've developed products that help meet that need," says CEO, Rob Fia.

The company's first groundbreaking proprietary technology provides effective, non-invasive, and painless skin care. Moreover, Therma Bright has been granted Class II medical device status by the FDA for its platform technology. Further, the technology is indicated for the relief of pain, itching, and inflammation from a variety of insect bites or stings. The company received FDA approval for the above claims in 1997.

In addition, Therma Bright has been working with engineers and designers to complete a prototype that will be tested for effectiveness against the Zika virus and other mosquito borne diseases. Once testing is complete the Company will seek any regulatory approvals. They will also outsource manufacturing and distribute TherOZap™ through distribution partners and online through social media channels.

For more information on Therma Bright Inc. (TSX.V: THRM) please fill out the form below.

You might also like

Ivan Bebek on Where the Biggest Mining Returns May Still Lie
Metals & Mining
March 4, 2026

Ivan Bebek on Where the Biggest Mining Returns May Still Lie

Veteran mining entrepreneur Ivan Bebek believes the current gold and silver cycle may only be getting started.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs
ETFs
March 3, 2026

BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs

In Canada, management fees for asset allocation ETFs can range from approximately 50 basis points down to 15 basis points.

This is some text inside of a div block.
Subscribe and receive the investor Info